Hansen Shannon Marie
Known title: SVP & General CounselCIK: 0001908267
Hansen Shannon Marie's purchase track record
Hansen Shannon Marie has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/8/2023 | TNDM | $30K | +50.5% | +171.6% | +18.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| TNDM | ▲ Buy | Option Exercise | 1,097 | $0 | 8/15/2026 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 559 | $13K | 8/15/2026 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 1,917 | $0 | 8/15/2026 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 976 | $22K | 8/15/2026 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 3,901 | $50K | 5/15/2026 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 7,667 | $0 | 5/15/2026 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 1,437 | $0 | 5/15/2026 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 732 | $9K | 5/15/2026 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 1,097 | $0 | 5/15/2026 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 559 | $7K | 5/15/2026 | View on chart |
| TNDM | ▲ Buy | Grant | 1,886 | $21K | 5/15/2026 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 1,437 | $0 | 2/17/2026 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 592 | $11K | 2/17/2026 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 1,097 | $0 | 2/17/2026 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 452 | $9K | 2/17/2026 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 531 | $0 | 2/17/2026 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 219 | $4K | 2/17/2026 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 530 | $0 | 11/17/2025 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 190 | $4K | 11/17/2025 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 1,437 | $0 | 11/17/2025 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 515 | $10K | 11/17/2025 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 1,096 | $0 | 11/17/2025 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 393 | $7K | 11/17/2025 | View on chart |
| TNDM | ▲ Buy | Grant | 800 | $12K | 11/17/2025 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 531 | $0 | 8/15/2025 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 190 | $2K | 8/15/2025 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 1,437 | $0 | 8/15/2025 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 515 | $6K | 8/15/2025 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 1,097 | $0 | 8/15/2025 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 393 | $4K | 8/15/2025 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 531 | $0 | 5/15/2025 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 190 | $4K | 5/15/2025 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 1,437 | $0 | 5/15/2025 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 515 | $12K | 5/15/2025 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 4,387 | $0 | 5/15/2025 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 1,570 | $36K | 5/15/2025 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 1,438 | $0 | 2/18/2025 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 219 | $7K | 2/18/2025 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 591 | $20K | 2/18/2025 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 531 | $0 | 2/18/2025 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 1,437 | $0 | 11/15/2024 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 513 | $14K | 11/15/2024 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 530 | $0 | 11/15/2024 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 190 | $5K | 11/15/2024 | View on chart |
| TNDM | ▲ Buy | Grant | 561 | $9K | 11/15/2024 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 531 | $0 | 8/15/2024 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 190 | $8K | 8/15/2024 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 1,437 | $0 | 8/15/2024 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 513 | $22K | 8/15/2024 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 531 | $0 | 5/15/2024 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 5,748 | $0 | 5/15/2024 | View on chart |
| TNDM | ▲ Buy | Grant | 799 | $12K | 5/15/2024 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 190 | $9K | 5/15/2024 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 2,051 | $97K | 5/15/2024 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 531 | $0 | 2/15/2024 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 218 | $5K | 2/15/2024 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 530 | $0 | 11/15/2023 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 184 | $3K | 11/15/2023 | View on chart |
| TNDM | ▲ Buy | Open Market | 1,935 | $30K | 11/8/2023 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 531 | $0 | 8/15/2023 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 184 | $5K | 8/15/2023 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 531 | $0 | 5/15/2023 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 184 | $6K | 5/15/2023 | View on chart |
| TNDM | ▲ Buy | Grant | 632 | $17K | 5/15/2023 | View on chart |
| TNDM | ▼ Sell | Tax Withholding | 866 | $37K | 2/16/2023 | View on chart |
| TNDM | ▲ Buy | Option Exercise | 2,123 | $0 | 2/16/2023 | View on chart |
| TNDM | ▲ Buy | Grant | 334 | $12K | 11/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Barclays initiates coverage on Tandem Diabetes Care with Equal-Weight rating
Barclays has started covering Tandem Diabetes Care, assigning it an Equal-Weight rating and a price target of $18. This new analyst view comes as the company prepares to discuss its Q2 2026 earnings. The $18 target is at the lower end of the current analyst consensus range, which averages $27.86.
Barclays initiates coverage on Tandem Diabetes Care with Equal-Weight rating. Barclays has started covering Tandem Diabetes Care, assigning it an Equal-Weight rating and a price target of $18. This new analyst view comes as the company prepares to discuss its Q2 2026 earnings. The $18 target is at the lower end of the current analyst consensus range, which averages $27.86.